Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Lees, A. J., Hardy, J. & Revesz, T. Parkinson’s disease. Lancet 373, 2055–2066 (2009).
2. De Rijk, M. C. et al. Prevalence of Parkinsonism and of Parkinson’s disease in elderly subjects; the ‘Rotterdam study’. Ned Tijdschr Geneeskd 140(4), 196–200 (1996).
3. Hornykiewicz, O. L-DOPA: from a biologically inactive amino acid to a successful therapeutic agent. Amino Acids 23(1–3), 65–70 (2002).
4. Miyasaki, J. M., Martin, W., Suchowersky, O., Weiner, W. J. & Lang, A. E. Practice parameter: initiation of treatment for Parkinson’s disease: an evidence-based review: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 58(1), 11–17 (2002).
5. Pan, T., Le, W. & Jankovic, J. Slowing Parkinson’s disease progression: recent dopamine agonist trials. Neurology 62, 343–344 (2004).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献